Notes
Latest data update
1 November 2023
| Title of page updated | Data sources | |
|---|---|---|
|
|
|
|
|
Title of page updated |
Data sources |
|---|---|
|
Tobacco |
|
|
Alcohol consumption |
|
|
Illicit drug use |
|
|
Prescription drug dispensing |
AIHW analysis of the Pharmaceutical Benefits Scheme (PBS) |
|
Alcohol and other drug-related ambulance attendances |
|
|
Drug-induced deaths |
|
|
International comparisons |
|
Table updates3: Harm minimisation
|
Title of page updated |
Data sources |
|---|---|
|
Demand reduction |
|
|
Supply reduction: Wastewater analysis |
National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. |
|
Harm reduction |
CanTEST Health and Drug Checking Service Program Evaluation: Final Report |
|
Title of page updated |
Data sources |
|---|---|
|
Health impacts |
AIHW analysis of the National Mortality Database AIHW analysis of the National Hospital Morbidity Database Australian Bureau of Statistics Causes of Death, Australia, Australian Bureau of Statistics |
|
Social impacts |
|
|
Economic impacts |
|
|
Title of page updated |
Data sources |
|---|---|
|
Tobacco: Consumption
Treatment |
National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. AIHW analysis of the Pharmaceutical Benefits Scheme (PBS) |
|
Alcohol: Availability Consumption Harms – Hospitalisations, Deaths Treatment |
Apparent consumption of alcohol in Australia, Australian Institute of Health and Welfare National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. AIHW analysis of the National Hospital Morbidity Database Causes of Death, Australia, Australian Bureau of Statistics AIHW analysis of the Pharmaceutical Benefits Scheme (PBS) |
|
Cannabis: Consumption Harms – Hospitalisations |
National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. AIHW analysis of the National Hospital Morbidity Database |
|
Meth/amphetamine and other stimulants: Consumption Harms – Hospitalisations |
National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. AIHW analysis of the National Hospital Morbidity Database |
|
Pharmaceuticals: Availability, Policy context Consumption Harms – Hospitalisations |
AIHW analysis of the Pharmaceutical Benefits Scheme (PBS) National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. AIHW analysis of the National Hospital Morbidity Database |
|
Illicit opioids, including heroin: Consumption |
National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. |
|
New (and emerging) psychoactive substances: Consumption |
National Wastewater Drug Monitoring Program Report 19, Australian Criminal Intelligence Commission. |
|
Title of page updated |
Data sources |
|---|---|
|
First Nations people |
Australia’s Annual Overdose Report 2023, Penington Institute |
|
People experiencing homelessness |
|
|
Older people: Pharmaceuticals, Treatment, Health and harms |
AIHW analysis of the Pharmaceutical Benefits Scheme (PBS) Causes of Death, Australia, Australian Bureau of Statistics |
|
People from culturally and linguistically diverse populations |
|
|
People in contact with the criminal justice system |
|
|
Lesbian, gay, bisexual, transgender, intersex, or queer people: Illicit drugs |
Australian Needle Syringe Program Survey National Data Report 2018–2022, Kirby Institute. |
|
People with mental health conditions |
|
|
Younger people: Health and harms |
Causes of Death, Australia, Australian Bureau of Statistics |
|
People who inject drugs: Illicit drugs, health, and harms |
Australian Needle Syringe Program Survey National Data Report 2018–2022, Kirby Institute. |